Ad
ELEV - Elevation Oncology Stock Trading
About | Elevation Oncology Inc. (NASDAQ:ELEV)
Quote | Elevation Oncology Inc. (NASDAQ:ELEV)
| Last: | $0.70 |
|---|---|
| Change Percent: | 4.77% |
| Open: | $0.6822 |
| Close: | $0.70 |
| High: | $0.72 |
| Low: | $0.6822 |
| Volume: | 32,179 |
| Last Trade Date Time: | 09/22/2023 03:00:00 am |
News | Elevation Oncology Inc. (NASDAQ:ELEV)
-
Elevation Oncology to Present at the H.C. Wainwright 25th Annual Global Investment Conference PR Newswire NEW YORK , Sept. 5, 2023 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and developmen...
-
Elevation Oncology Announces First Patient Dosed in the Phase 1 Clinical Trial Evaluating EO-3021 PR Newswire NEW YORK , Aug. 16, 2023 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of sele...
Message Board Posts | Elevation Oncology Inc. (NASDAQ:ELEV)
| Subject | By | Source | When |
|---|---|---|---|
| $ELEV Price gaining | Invest-in-America | investorshub | 04/22/2023 1:49:51 PM |
| $ELEV MomentumIts gaining | Mt. Blanc | investorshub | 04/19/2023 3:56:59 PM |
| Price trading last trade up | RNsidersbuying | investorshub | 04/19/2023 8:07:39 AM |
| MomentumIts trading | Mt. Blanc | investorshub | 04/18/2023 12:38:48 AM |
| are we finally gonna see some action | Mt. Blanc | investorshub | 04/16/2023 11:11:06 PM |
Elevation Oncology Inc. Company Name:
ELEV Stock Symbol:
NASDAQ Market:
Elevation Oncology Inc. Website:
Ad
-
ELEV - Elevation Oncology to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Elevation Oncology to Present at the H.C. Wainwright 25th Annual Global Investment Conference PR Newswire NEW YORK , Sept. 5, 2023 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and developmen...
-
Elevation Oncology Announces First Patient Dosed in the Phase 1 Clinical Trial Evaluating EO-3021 PR Newswire NEW YORK , Aug. 16, 2023 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of sele...
-
Elevation Oncology Reports Second Quarter 2023 Financial Results and Highlights Recent Business Achievements PR Newswire Initial Phase 1 SYSA1801 (EO-3021) data presented by partner CSPC Pharmaceutical Group Limited at ASCO 2023 showed promising signs of efficacy, inclu...